BioSpace News Archive

Ventus Therapeutics U.S., Inc. today announced the appointments of Jane Henderson, Dolca Thomas, M.D. and Markus Warmuth, M.D. to the company’s Board of Directors.

MedAvail Holdings, Inc. today announced that the company will be participating in the upcoming Lytham Partners Winter 2021 Investor Conference.

Massive Bio, Inc. announced the launch of its 100K CANCER CLINICAL TRIAL SINGULARITY PROGRAM.

Inertial Labs, an industry leading developer and supplier of orientation, inertial navigation, and optically enhanced sensor modules has acquired MEMSENSE, a developer of inertial measurement units that lead the market in performance and value.

Twist Bioscience Corporation today announced the launch of the Twist cfDNA Pan-cancer Reference Standards , a high-quality standardized control for use in the development and continuous monitoring of liquid biopsy tests to detect cancer from blood samples.

Pharvaris today announced the appointment of Elisabeth Björk, M.D., to the board of directors with expected confirmation at the company’s 2022 annual general meeting of shareholders.

Aerami Therapeutics Holdings, Inc., a biopharmaceutical company focused on developing inhaled therapies to treat severe respiratory and chronic diseases, and FoxWayne Enterprises Acquisition Corp., a special purpose acquisition company, announced they have entered into a definitive business combination agreement.

Capital for commercialization of SparkRx for adolescent depression and exploration of new digital therapeutics to address mental health needs in pediatrics.

Takeda Unveils New Research to Advance Patient Care in Hematology and Oncology at 63rd American Society of Hematology (ASH) Annual Meeting.

IMMUNOPRECISE ANTIBODIES LTD. today announced that it will host a conference call to discuss its financial results and recent business highlights for second quarter fiscal year 2022 on December 13, 2021, after the close of market.